JENSEN JESSICA D. 4
4 · POINT Biopharma Global Inc. · Filed Apr 5, 2022
Insider Transaction Report
Form 4
JENSEN JESSICA D.
EVP Clinical Development
Transactions
- Award
Stock Option (Right to Buy)
2022-04-01+13,766→ 13,766 totalExercise: $7.91Exp: 2028-04-01→ Common Stock (13,766 underlying)
Footnotes (1)
- [F1]The option vests 25% on the first anniversary of the date of grant with the remaining 75% vesting in three equal annual installments thereafter.